Moreover, the CU06-1004 group had significantly decreased pro-inflammatory cytokines such as interleukin-6 (IL-6; in mild NASH) and significantly decreased serum TNF-α in moderate NASH (Fig 3F and 3G). This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.